Galmed Pharmaceuticals (GLMD) Tax Rate (2013 - 2018)
Galmed Pharmaceuticals (GLMD) posted quarterly Tax Rate of 8.48% for Q3 2018, up 201.15% quarter-over-quarter from 2.82% in Q3 2016.
Galmed Pharmaceuticals (GLMD) Tax Rate (2013 - 2018) Analysis & Trends
Galmed Pharmaceuticals' Tax Rate history runs 4 years deep, the most recent figure standing at 8.48% for Q3 2018.
- In Q3 2018, Tax Rate changed N/A year-over-year to 8.48%; the TTM figure through Dec 2018 stood at 1.63% (changed N/A YoY), while the FY2024 annual figure was 5.82%, changed N/A from the prior year.
- Tax Rate for Q3 2018 stood at 8.48%, up from 2.82% in the prior quarter.
- The five-year high for Tax Rate was 8.48% in Q3 2018, with the low at 0.02% in Q2 2016.
- The 3-year median for Tax Rate is 1.46% (2014), against an average of 2.86%.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.91% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 24.15% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 7.49% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 34.12% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.71% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Galmed Pharmaceuticals | 2.31 Mn | -9.57 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 8.48% |
| Sep 30, 2018 | 8.48% |
| Sep 30, 2018 | 8.48% |
| Sep 30, 2016 | 2.82% |
| Sep 30, 2016 | 2.82% |
| Sep 30, 2016 | 2.82% |
| Jun 30, 2016 | 0.02% |
| Jun 30, 2016 | 0.02% |
| Jun 30, 2016 | 0.02% |
| Mar 31, 2014 | 0.10% |
| Mar 31, 2014 | 0.10% |
| Mar 31, 2014 | 0.10% |
| Dec 31, 2013 | 0.01% |
| Dec 31, 2013 | 0.01% |
| Dec 31, 2013 | 0.01% |